300 IR house dust mites allergen extract tablet

DRUG3 trials

Sponsors

Stallergenes Greer

Conditions

Allergic RhinitisAllergic Rhinitis Due to Dust MiteAllergic Rhinitis Due to House Dust Mite

Phase 2

Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis

CompletedNCT00674700

Stallergenes GreerAllergic Rhinitis

Start: 2007-10-31End: 2010-02-28Updated: 2016-05-19

Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite Tablets in Allergic Rhinitis Environment Exposure Chamber Model

CompletedNCT01527188

Stallergenes GreerAllergic Rhinitis Due to House Dust Mite

Start: 2010-12-08End: 2012-09-19Updated: 2025-02-04

Phase 3

Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis in Adolescents and Children

TerminatedNCT01199133

Stallergenes GreerAllergic Rhinitis Due to Dust Mite

Start: 2009-10-31End: 2011-09-30Updated: 2025-02-11

Related Papers

Safety of 300IR house dust mite sublingual tablet from pooled clinical trial and post-marketing data.

2024-06-251 citations

P60: TREATMENT WITH HOUSE DUST MITE SUBLINGUAL TABLETS IN ALLERGIC RHINITIS SUBJECTS: HOUSE DUST MITE SPECIFIC IgE AND IgG<sub>4</sub> RESULTS

Internal Medicine Journal2017-09-01

Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.

2012-10-0124 citations